Started Jun 27, 2021 03:00AM UTC   •   Closed Oct 01, 2021 07:01AM UTC

The Economist asks:

Will the US FDA approve a drug used to reverse the effects of Alzheimer's disease on the brain and/or approve a vaccine to prevent Alzheimer's disease as of 2035?

Alzheimer's disease accounts for 60-80% of dementia cases (Alzheimer's Association). The outcome will be determined using available FDA approval data available as of 31 December 2035. "Expanded access/compassionate use," "accelerated approval," and "emergency use" authorizations would not count (FDA - Expanded Access, FDA - Accelerated Approval, FDA - Emergency Use Authorization).

This question will be suspended on 1 October 2021. While forecasts on this question may be evaluated in the years to come, they will not be scored.

Confused? Check our FAQ or ask us for help. To learn more about Good Judgment and Superforecasting, click here.

To learn more about how you can become a Superforecaster, see hereFor other posts from our Insights blog, click here.

This question has been voided by an administrator and is no longer active.

Long-term, unscored question
Tip: Mention someone by typing @username